Citation: | ZHANG Lijing, WANG Yuanyuan, ZHAI Congjie, DU Zhijian, HAN Xiaodong, ZHAO Zengren. MicroRNA-31 Expression in Colorectal Cancer and Bioinformatic Analysis of Its Predicted Target Genes[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 1005-1010. DOI: 10.3971/j.issn.1000-8578.2015.10.012 |
[1] |
Ambros V. The functions of animal microRNAs[J]. Nature, 2004, 43 1(7006): 350-5.
|
[2] |
Zhang LJ, Zhao ZR, Zhang ZY, et al. Differential expressions of microRNAs in rectal adenocarcinoma tissues[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41(6): 602-5. [张丽静, 赵增仁, 张志勇, 等. 直 肠腺癌组织中microRNA差异表达谱分析[J]. 肿瘤防治研究, 20 14, 41(6): 602-5.]
|
[3] |
Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin[J]. Nat Biotechnol, 2008, 26(4): 46 2-9.
|
[4] |
Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs[J]. Nature, 2005, 433(7027): 769-73.
|
[5] |
Xu Y, Sun J, Xu J, et al. miR-21 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer[J]. Gastroenterol Res Pract, 2012, 2012: 640168.
|
[6] |
Selcuklu SD, Donoghue MT, Rehmet K, et al. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells[J]. J Biol Chem, 2012, 287(35): 29516-28.
|
[7] |
Zhang L, Dong Y, Zhu N, et al. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer[J]. Mol Cancer, 2014, 13: 124.
|
[8] |
Wang CJ, Zhou ZG, Wang L, et al. Clinicopathological significance of microRNA-31, -143 and -45 expression in colorectal cancer[J]. Dis Markers, 2009, 26(1): 27-34.
|
[9] |
Bandrés E1, Cubedo E, Agirre X, et al. Identification by Realtime PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues[J]. Mol Cancer, 2006, 5: 29.
|
[10] |
Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis[J]. Cell, 20 09, 137(6): 1032-46.
|
[11] |
Guo J, Miao Y, Xiao B, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues[J]. J Gastroenterol Hepatol, 2009, 24(4): 652-7.
|
[12] |
Papaconstantinou IG, Manta A, Gazouli M, et al. Expression of microRNAs in patients with pancreatic cancer and its prognostic[J]. Pancreas, 2013, 42(1): 67-71.
|
[13] |
Motoyama K, Inoue H, Takatsuno Y, et al. Over- and underexpressed microRNAs in human colorectal cancer[J]. Int J Oncol, 20 09, 34(4): 1069-75.
|
[14] |
Lei SL, Zhao H, Yao HL, et al. Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells[J]. Oncol Lett, 2014, 8(4): 1768-74.
|
[15] |
Manceau G, Imbeaud S, Thiébaut R, et al. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti- EGFR therapy[J]. Clin Cancer Res, 2014, 20(12): 3338-47.
|
[16] |
Kinzler KW, Vogelstein B. Lessons from hereditar colorectal cancer[J]. Cell, 1996, 87(2): 159-70.
|
[17] |
Chen T, Yao LQ, Shi Q, et al. MicroRNA-31 contributes to colorectal cancer development by targeting factor inhibiting HIF-1α (FIH-1)[J]. Cancer Biol Ther, 2014, 15(5): 516-23.
|
[18] |
Yang MH, Yu J, Chen N, et al. Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2[J]. PLoS One, 2013, 8(12): e85353.
|